Vous trouverez ci-dessous une liste des publications scientifiques en lien avec la thématique « maladie rare » sur les 5 dernières années (2018-22) 

 

• Dans la sclérodermie systémique

                                                                                                               

(les articles en lien avec la collaboration avec EUSTAR ne sont pas présentés)

 

• Combining systemic and locally applied cellular therapies for the treatment of systemic sclerosis. Velier M, Daumas A, Simoncini S, Arcani R, Magalon J, Benyamine A, Granel B, Dignat George F, Chabannon C, Sabatier F.

Bone Marrow Transplant. 2022 Jan;57(1):17-22. doi: 10.1038/s41409-021-01492-7. Epub 2021 Oct 18. PMID: 34663928.

 

• CD146 at the interface between oxidative stress and the Wnt signaling pathway in systemic sclerosis. Heim X, Bermudez J, Joshkon A, Kaspi E, Bachelier R, Nollet M, Vélier M, Dou L, Brodovitch A, Foucault-Bertaud A, Leroyer AS, Benyamine A, Daumas A, Granel B, Sabatier F, Dignat-George F, Blot-Chabaud M, Bardin N.

J Invest Dermatol. 2022 Jun 8:S0022-202X(22)01528-7. doi: 10.1016/j.jid.2022.03.038. Epub ahead of print. PMID: 35690141.

 

•  Involvement of Multiple Variants of Soluble CD146 in Systemic Sclerosis: Identification of a Novel Profibrotic Factor. Nollet M, Bachelier R, Joshkon A, Traboulsi W, Mahieux A, Moyon A, Muller A, Somasundaram I, Simoncini S, Peiretti F, Leroyer AS, Guillet B, Granel B, Dignat-George F, Bardin N, Foucault-Bertaud A, Blot-Chabaud M.

Arthritis Rheumatol. 2022 Jun;74(6):1027-1038. doi: 10.1002/art.42063. Epub 2022 Apr 11. PMID: 35001552.

 

• Multiple variants of soluble CD146 are involved in Systemic Sclerosis: identification of a novel pro-fibrotic factor.

Nollet M, Bachelier R, Joshkon A, Traboulsi W, Mahieux A, Moyon A, Muller A, Somasundaram I, Simoncini S, Peiretti F, Leroyer AS, Guillet B, Granel B, Dignat-George F, Bardin N, Foucault-Bertaud A, Blot-Chabaud M.

Arthritis Rheumatol. 2022 Jan 9. doi: 10.1002/art.42063. Online ahead of print.

 

• Quantification of Antifibrillarin (anti-U3 RNP) Antibodies: A New Insight for Patients with Systemic Sclerosis.

Benyamine A, Bertin D, Resseguier N, Heim X, Bermudez J, Launay D, Dubucquoi S, Hij A, Farge D, Lescoat A, Bahon-Riedinger I, Benmostefa N, Mouthon L, Harlé JR, Kaplanski G, Rossi P, Bardin N, Granel B.

Diagnostics (Basel). 2021 Jun 9;11(6):1064. doi: 10.3390/diagnostics11061064.

 

• Adipose tissue-derived stromal vascular fraction for treating hands of patients with systemic sclerosis: a multicentre randomized trial.

Daumas A, Magalon J, Jouve E, Casanova D, Philandrianos C, Abellan Lopez M, Mallet S, Veran J, Auquit-Auckbur I, Farge D, Levesque H, Benhamou Y, Arnaud L, Giraudo L, Dumoulin C, Giverne C, Boyer O, Giuliani A, Bourgarel V, Harlé JR, Schleinitz N, Brunet J, Pers YM, Ferreira R, Cras A, Bocara D, Larghero J, Château J, Hot A, Dignat-George F, Magalon G, Sabatier F, Granel B.

Rheumatology (Oxford). 2021 Jul 23:keab584. doi: 10.1093/rheumatology/keab584. 

 

• Oesophageal motor disorders and oesophageal endoscopic involvement in patients with systemic sclerosis: a systematic association?

Vitton V, Bazin C, Luciano L, Granel B, Alessandrini M, Harle JR.

Scand J Gastroenterol. 2021 May;56(5):508-513. doi: 10.1080/00365521.2021.1881813. 

 

• G-POEM may be an optional treatment for refractory gastroparesis in systemic sclerosis.

Gonzalez JM, Granel B, Barthet M, Vitton V.

Scand J Gastroenterol. 2020 Jul;55(7):777-779. doi: 10.1080/00365521.2020.1761997. 

 

• Osteitis in Systemic Sclerosis: a nationwide case-control retrospective study (SCLEROS Study).

Cosse C, Kernéis S, Lescoat A, Pugnet G, Truchetet ME, Priollet P, Diot E, Martin M, Maurier F, Viallard JF, Agard C, Granel B, Berthier S, Fagedet D, Watelet B, Toquet S, Luque Paz D, Giret C, Cerles O, Dion J, Nguyen C, Raffray L, Bertolino J, Jourde W, Le Jeunne C, Mouthon L, Chaigne B.

Arthritis Care Res (Hoboken). 2020 Dec 5. doi: 10.1002/acr.24530. 

 

• Fat Grafting for Treatment of Facial Scleroderma. Daumas A, Magalon J, Delaunay F, Abellan M, Philandrianos C, Sabatier F, Granel B, Magalon G.

Clin Plast Surg. 2020 Jan;47(1):155-163. doi: 10.1016/j.cps.2019.08.016. Epub 2019 Oct 28

 

• Adipose-Derived Stem Cells from Systemic Sclerosis Patients Maintain Pro-Angiogenic and Antifibrotic Paracrine Effects In Vitro.

Velier M, Simoncini S, Abellan M, Francois P, Eap S, Lagrange A, Bertrand B, Daumas A, Granel B, Delorme B, Dignat George F, Magalon J, Sabatier F.

J Clin Med. 2019 Nov 14;8(11):1979. doi: 10.3390/jcm8111979.

 

• TH17 cells expressing CD146 are significantly increased in patients with Systemic sclerosis.

Gabsi A, Heim X, Dlala A, Gati A, Sakhri H, Abidi A, Amri S, Neili B, Leroyer AS, Bertaud A, Smiti Khanfir M, Said F, Houman MH, Granel B, Blot-Chabaud M, Bardin N, Marrakchi R.

Sci Rep. 2019 Nov 27;9(1):17721. doi: 10.1038/s41598-019-54132-y.

 

• Soluble HLA-G Expression Inversely Correlates With Fetal Microchimerism Levels in Peripheral Blood From Women With Scleroderma.

Di Cristofaro J, Karlmark KR, Kanaan SB, Azzouz DF, El Haddad M, Hubert L, Farge-Bancel D, Granel B, Harlé JR, Hachulla E, Pardoux E, Roudier J, Picard C, Lambert NC.

Front Immunol. 2018 Aug 14;9:1685. doi: 10.3389/fimmu.2018.01685. eCollection 2018.

 

• Molecular profile and proangiogenic activity of the adipose-derived stromal vascular fraction used as an autologous innovative medicinal product in patients with systemic sclerosis.

Magalon J, Velier M, Simoncini S, François P, Bertrand B, Daumas A, Benyamine A, Boissier R, Arnaud L, Lyonnet L, Fernandez S, Dignat-George F, Casanova D, Guillet B, Granel B, Paul P, Sabatier F.

Ann Rheum Dis. 2019 Mar;78(3):391-398. doi: 10.1136/annrheumdis-2018-214218. Epub 2019 Jan 5.

 

• Response to: 'Adipose stromal vascular fraction and regenerative therapy in SSc: response to the article by Magalon et al' by De Benedetto et al.

Magalon J, Velier M, Simoncini S, Dignat-George F, Granel B, Paul P, Sabatier F.

Ann Rheum Dis. 2020 May;79(5):e54. doi: 10.1136/annrheumdis-2019-215132. Epub 2019 Feb 20.

 

• Response to: 'Could autologous adipose-derived stromal vascular fraction turn out an unwanted source of profibrotic myofibroblasts in systemic sclerosis?' by Manetti.

Velier M, Magalon J, Simoncini S, Dignat-George F, Granel B, Paul P, Sabatier F.

Ann Rheum Dis. 2020 May;79(5):e56. doi: 10.1136/annrheumdis-2019-215327. Epub 2019 Apr 9.

 

• Elevated serum Krebs von den Lungen-6 in systemic sclerosis: a marker of lung fibrosis and severity of the disease.

Benyamine A, Heim X, Resseguier N, Bertin D, Gomez C, Ebbo M, Harlé JR, Kaplanski G, Rossi P, Bardin N, Granel B.

Rheumatol Int. 2018 May;38(5):813-819. doi: 10.1007/s00296-018-3987-3. Epub 2018 Feb 17.

 

• Natural Killer Cells Exhibit a Peculiar Phenotypic Profile in Systemic Sclerosis and Are Potent Inducers of Endothelial Microparticles Release.

Benyamine A, Magalon J, Sabatier F, Lyonnet L, Robert S, Dumoulin C, Morange S, Mazodier K, Kaplanski G, Reynaud-Gaubert M, Rossi P, Dignat-George F, Granel B, Paul P.

Front Immunol. 2018 Jul 18;9:1665. doi: 10.3389/fimmu.2018.01665. eCollection 2018.

 

 

 

• Dans les vascularites             

                 

• Pericardial effusion in giant cell arteritis is associated with increased inflammatory markers: a retrospective cohort study.

Gomes de Pinho Q, Daumas A, Benyamine A, Bertolino J, Rossi P, Schleinitz N, Harlé JR, Jarrot PA, Kaplanski G, Berbis J, Granel B.
Rheumatol Int. 2022 May 7.                                                           

 

• Different patterns and specific outcomes of large-vessel involvements in giant cell arteritis.

de Boysson H, Liozon E, Espitia O, Daumas A, Vautier M, Lambert M, Parienti JJ, Granel B, Dumont A, Sultan A, Manrique A, Saadoun D, Ly KH, Agard C, Aouba A.

J Autoimmun. 2019 Sep;103:102283. doi: 10.1016/j.jaut.2019.05.011. 

 

• Vascular Presentation and Outcomes of Patients With Giant Cell Arteritis and Isolated Symptomatic Limb Involvement.

de Boysson H, Espitia O, Liozon E, Daumas A, Vautier M, Dumont A, Granel B, Saadoun D, Planchard G, Ly KH, Aouba A.

J Clin Rheumatol. 2020 Sep;26(6):248-254. doi: 10.1097/RHU.0000000000001051.

 

• Characteristics of giant cell arteritis patients under and over 75-years-old: A comparative study on 164 patients.

Daumas A, Bichon A, Rioland C, Benyamine A, Berbis J, Ebbo M, Jarrot PA, Gayet S, Rossi P, Schleinitz N, Harle JR, Kaplanski G, Villani P, Granel B. 

Rev Med Interne. 2019 May;40(5):278-285. doi: 10.1016/j.revmed.2018.11.004. 

 

•  Immunomodulatory role of Interleukin-33 in large vessel vasculitis

Anne-Claire Desbois, Patrice Cacoub, Aurélie S. Leroyer, Edwige Tellier, Marlène Garrido, Anna Maciejewski-Duval, Cloé Comarmond, Stéphane Barete, Michel Arock, Patrick Bruneval, Jean-Marie Launay, Pierre Fouret, Ulrich Blank, Michelle Rosenzwajg, David Klatzmann, Mohamed Jarraya, Philippe Cluzel, Fabien Koskas, Gilles Kaplanski, David Saadoun 

Sci Rep. 2020; 10: 6405.

 

• Mast cells drive pathologic vascular lesions in Takayasu arteritis. 

Le Joncour A, Desbois AC, Leroyer AS, Tellier E, Régnier P, Maciejewski-Duval A, Comarmond C, Barete S, Arock M, Bruneval P, Launay JM, Fouret P, Blank U, Rosenzwajg M, Klatzmann D, Jarraya M, Chiche L, Koskas F, Cacoub P, Kaplanski G, Saadoun D.

 J Allergy Clin Immunol. 2022 Jan;149(1):292-301.e3. doi: 10.1016/j.jaci.2021.05.003. 

 

• French recommendations for the management of Behçet’s disease

Isabelle Kone-Paut, Stéphane Barete, Bahram Bodaghi, Kumaran Deiva, Anne-Claire Desbois, Caroline Galeotti, Julien Gaudric, Gilles Kaplanski, Alfred Mahr, Nicolas Noel, Maryam Piram, Tu-Anh Tran, Bertrand Wechsler, David Saadoun, Collaborators

Orphanet J Rare Dis. 2021; 16(Suppl 1): 352. Published online 2021 Feb 24. doi: 10.1186/s13023-020-01620-4

 

• Bilateral Breast Ulcers: Granulomatosis with Polyangiitis. 

Jarrot PA, Pelletier ML, Brun M, Penicaud M, Mazodier K, Benyamine A, Grande JD, Jean R, Casanova D, Kaplanski G, Weiller PJ.

Am J Med. 2019 Feb;132(2):179-181. doi: 10.1016/j.amjmed.2018.09.008. 

 

• Neutrophil extracellular traps are associated with the pathogenesis of diffuse alveolar hemorrhage in murine lupus. 

Jarrot PA, Tellier E, Plantureux L, Crescence L, Robert S, Chareyre C, Daniel L, Secq V, Garcia S, Dignat-George F, Panicot-Dubois L, Dubois C, Kaplanski G. 

J Autoimmun. 2019 Jun;100:120-130. doi: 10.1016/j.jaut.2019.03.009. 

 

• Endothelium structure and function in kidney health and disease.

N Jourde-Chiche, F Fakhouri, J Bellien, S Burtey, M Frimat, PA Jarrot, G Kaplanski, M Le Quintrec, V Pernin, C Rigothier, M Sallée, V Fremeaux-Bacchi, D Guerrot, LT Roumenina

Nat Rev Nephrol, 2019, Jan 3        

 

• Biopsy-proven kidney involvement in hypocomplementemic urticarial vasculitis.

Corthier A, Jachiet M, Bertin D, Servais A, Barbet C, Bigot A, Doutre MS, Bessis D, Bouffandeau A, Moranne O, Jarrot PA, Bardin N, Terrier B, Burtey S, Puéchal X, Daniel L, Jourde-Chiche N.BMC Nephrol. 2022 Feb 16;23(1):67. doi: 10.1186/s12882-022-02689-8.PMID: 35172758

 

• Assessment of the efficacy and safety of tocilizumab in patients over 80 years old with giant cell arteritis.

de Boysson H, Le Besnerais M, Blaison F, Daumas A, Jarrot PA, Perrin F, Tieulié N, Maria A, Duffau P, Gombert B, Samson M, Espitia O, Lambert M, Mékinian A, Aouba A; French Study Group for Large Vessel Vasculitis (GEFA). Arthritis Res Ther. 2021 May 19;23(1):143. doi: 10.1186/s13075-021-02529-4.

 

• Retinal vasculitis and systemic diseases

Gascon P, Jarrot PA, Matonti F, Kaplanski G.Rev Med Interne. 2018 Sep;39(9):721-727. doi: 10.1016/j.revmed.2018.04.013. 

 

•  Vasculitis associated with myelodysplastic syndrome and chronic myelomonocytic leukemia:

French multicenter case-control study. 

Roupie AL, Guedon A, Terrier B, Lahuna C, Jachiet V, Regent A, de Boysson H, Carrat F, Seguier J, Terriou L, Versini M, Queyrel V, Groh M, Benhamou Y, Maurier F, Ledoult E, Clech LL, D'Aveni M, Rossignol J, Galland J, Willems L, Chiche NJ, Peterlin P, Roux-Sauvat M, Parcelier A, Wemeau M, Lambert M, Belizna C, Puechal X, Swiader L, Cohen-Valensi R, Noc V, Dao E, Thepot S, de Frémont GM, Tanguy-Schmidt A, Koka AM, Bussone G, Philipponnet C, Konate A, Cavaille G, Guilpain P, Allain JS, Broner J, Solary E, Ruivard M, de Renzis B, Corm S, Baati N, Schleinitz N, Ponsoye M, Stamatoullas-Bastard A, Ades L, Dellal A, Tchirkov A, Aouba A, Fenaux P, Fain O, Mekinian A; On behalf MINHEMON (French Network of dysimmune disorders associated with hemopathies) and SNFMI. 

Semin Arthritis Rheum. 2020 Oct;50(5):879-884. 

 

• Infliximab is an effective glucocorticoid-sparing treatment for Takayasu arteritis: Results of a multicenter open-label prospective study. 

Mertz P, Kleinmann JF, Lambert M, Puéchal X, Bonnin A, Boulon C, Diot E, Hachulla E, Harid N, Harle JR, Helder G, Kahn JE, Kone-Paut I, Lavigne C, Magy-

Bertrand N, Maillard H, Martin T, Maurier F, Poindron V, Schleinitz N, Sibili J, Arnaud L. 

Autoimmun Rev. 2020 Oct;19(10):102634. 

 

• Long-Term Rituximab Use to Maintain Remission of Antineutrophil Cytoplasmic Antibody-Associated Vasculitis: A Randomized Trial. 

Charles P, Perrodeau É, Samson M, Bonnotte B, Néel A, Agard C, Huart A, Karras A, Lifermann F, Godmer P, Cohen P, Hanrotel-Saliou C, Martin-Silva N, Pugnet G, Maurier F, Sibilia J, Carron PL, Gobert P, Meaux-Ruault N, Le Gallou T, Vinzio S, Viallard JF, Hachulla E, Vinter C, Puéchal X, Terrier B, Ravaud P, Mouthon L, Guillevin L; French Vasculitis Study Group. 

Ann Intern Med. 2020 Aug 4;173(3):179-187. 

 

• Giant-cell arteritis associated with myelodysplastic syndrome: French multicenter case control study and literature review. 

Roupie AL, de Boysson H, Thietart S, Carrat F, Seguier J, Terriou L, Versini M, Queyrel V, Groh M, Benhamou Y, Maurier F, Decaux O, d'Aveni M, Rossignol J, Galland J, Solary E, Willems L, Schleinitz N, Ades L, Dellal A, Samson M, Aouba A, Fenaux P, Fain O, Mekinian A; On behalf MINHEMON (French Network of dysimmune disorders associated with hemopathies).

Autoimmun Rev. 2020 Feb;19(2):102446.

 

• Management of nonviral mixed cryoglobulinemia vasculitis refractory to rituximab: Data from a European collaborative study and review of the literature.

Pouchelon C, Visentini M, Emmi G, le Guern V, Quartuccio L, Samson M, Venhoff N, Briantais A, Casato M, Chatelus E, Chilles M, Cid MC, Diot E, Ebbo M, Faguer S, Hellmich B, Jachiet M, Moulinet T, Perrin F, Quémeneur T, Sinico RA, Terrier B. 

Autoimmun Rev. 2022 Jan 4;21(4):103034.

 

• Expanding the spectrum of VEXAS syndrome: association with acute-onset CIDP.

Bert-Marcaz C, Briantais A, Faucher B, Corazza G, Ebbo M, Attarian S, Delmont E, Fortanier E. 

J Neurol Neurosurg Psychiatry. 2021 Dec 6:jnnp-2021-327949. 

 

• Further characterization of clinical and laboratory features in VEXAS syndrome: large-scale analysis of a multicentre case series of 116 French patients.

Georgin-Lavialle S, Terrier B, Guedon AF, Heiblig M, Comont T, Lazaro E, Lacombe V, Terriou L, Ardois S, Bouaziz JD, Mathian A, Le Guenno G, Aouba A, Outh R, Meyer A, Roux-Sauvat M, Ebbo M, Zhao LP, Bigot A, Jamilloux Y, Guillotin V, Flamarion E, Henneton P, Vial G, Jachiet V, Rossignol J, Vinzio S, Weitten T, Vinit J, Deligny C, Humbert S, Samson M, Magy-Bertrand N, Moulinet T, Bourguiba R, Hanslik T, Bachmeyer C, Sebert M, Kostine M, Bienvenu B, Biscay P, Liozon E, Sailler L, Chasset F, Audemard-Verger A, Duroyon E, Sarrabay G, Borlot F, Dieval C, Cluzeau T, Marianetti P, Lobbes H, Boursier G, Gerfaud-Valentin M, Jeannel J, Servettaz A, Audia S, Larue M, Henriot B, Faucher B, Graveleau J, de Sainte Marie B, Galland J, Bouillet L, Arnaud C, Ades L, Carrat F, Hirsch P, Fenaux P, Fain O, Sujobert P, Kosmider O, Mekinian A; French VEXAS group; GFEV, GFM, CEREMAIA, MINHEMON. 

Br J Dermatol. 2022 Mar;186(3):564-574.

 

• ANCA-associated vasculitides: Recommendations of the French Vasculitis Study Group on the use of immunosuppressants and biotherapies for remission induction and maintenance.

Terrier B, Charles P, Aumaître O, Belot A, Bonnotte B, Crabol Y, Durel CA, Ebbo M, Jourde-Chiche N, Lega JC, Puéchal X, Pugnet G, Quemeneur T, Ribi C, Samson M, Vandergheynst F, Guillevin L; French Vasculitis Study Group.

Presse Med. 2020 Oct;49(3):104031.

 

• Large-vessel vasculitis diagnosed between 50 and 60 years: Case-control study based on 183 cases and 183 controls aged over 60 years.

Delaval L, Daumas A, Samson M, Ebbo M, De Boysson H, Liozon E, Dupuy H, Puyade M, Blockmans D, Benhamou Y, Sacré K, Berezne A, Devilliers H, Pugnet G, Maurier F, Zénone T, de Moreuil C, Lifermann F, Arnaud L, Espitia O, Deroux A, Grobost V, Lazaro E, Agard C, Balageas A, Bouiller K, Durel CA, Humbert S, Rieu V, Roriz M, Souchaud-Debouverie O, Vinzio S, Nguyen Y, Régent A, Guillevin L, Terrier B. 

Autoimmun Rev. 2019 Jul;18(7):714-720. 

 

• Autoimmune diseases in myelodysplastic syndrome favors patients survival: A case control study and literature review.

Seguier J, Gelsi-Boyer V, Ebbo M, Hamidou Z, Charbonnier A, Bernit E, Durand JM, Harlé JR, Vey N, Schleinitz N. 

Autoimmun Rev. 2019 Jan;18(1):36-42.

 

• Large-vessel involvement and aortic dilation in giant-cell arteritis. A multicenter study of 549 patients.

de Boysson H, Daumas A, Vautier M, Parienti JJ, Liozon E, Lambert M, Samson M, Ebbo M, Dumont A, Sultan A, Bonnotte B, Manrique A, Bienvenu B, Saadoun D, Aouba A. 

Autoimmun Rev. 2018 Apr;17(4):391-398.

 

• Dans le lupus, SAPL et syndrome de Sjogren

• Hydroxychloroquine-related hyperpigmentation.

• Relevance of systematic anti-nuclear antibodies testing after obstetrical complications.

Koubi M, Rossi P, Arcani R, Gomes De Pihno Q, Chau C, Blanc J, Grosdidiser C, Guervilly C, Bretelle F, Bernard-Guervilly F. Journal of Reproductive Immunology 2022

 

• Successful treatment of systemic lupus erythematosus-related refractory autoimmune hemolytic anemia with ofatumumab.

Poulet A, Jarrot PA, Mazodier K, Jean R, Kaplanski G.  Lupus. 2019 Dec;28(14):1735-1736. doi: 10.1177/0961203319881500. 

 

• Axial Articular Manifestations in Primary Sjögren Syndrome: Association With Spondyloarthritis. 

Jarrot PA, Arcani R, Darmon O, Roudier J, Cauchois R, Mazodier K, Jean R, Balandraud N, Kaplanski G.

 J Rheumatol. 2021 Jul;48(7):1037-1046. doi: 10.3899/jrheum.200189. Epub 2020 Jul 15.

 

• Anti-NuMA antibodies: clinical associations and significance in patients with primary Sjögren's syndrome or systemic lupus erythematosus. 

Arcani R, Bertin D, Bardin N, Mazodier K, Jean R, Suchon P, Venton G, Daumas A, Jean E, Villani P, Kaplanski G, Jarrot PA. 

Rheumatology (Oxford). 2021 Sep 1;60(9):4074-4084. 

 

• Brain 18F-fluorodeoxyglucose positron emission tomography/computed

tomography detection of neuropsychiatric lupus with normal cerebral magnetic

resonance imaging. Soubrier C, Faucher B, Guedj E, Kaphan E, Ebbo M, De Sainte Marie B,

Schleinitz N.  Rheumatology (Oxford). 2020 Feb 1;59(2):457.

 

• Immune thrombocytopenia with clinical significance in systemic lupus erythematosus: a retrospective cohort study of 90 patients. 

Roussotte M, Gerfaud-Valentin M, Hot A, Audia S, Bonnotte B, Thibault T, Lobbes H, Le Guenno G, Goulabchand R, Cathebras P, Varron L, Dufour JF, Deroux A, Compain C, Baudet A, Karkowski L, Pérard L, Ebbo M, Lega JC, Sève P. 

Rheumatology (Oxford). 2021 Dec 16:keab925.

 

• Safety and efficacy of low-dose intravenous arsenic trioxide in systemic lupus erythematosus: an open-label phase IIa trial (Lupsenic).

Hamidou M, Néel A, Poupon J, Amoura Z, Ebbo M, Sibilia J, Viallard JF, Gaborit B, Volteau C, Hardouin JB, Hachulla E, Rieger F.

Arthritis Res Ther. 2021 Mar 3;23(1):70.

 

• Bilateral adrenal hemorrhage under apixaban in primary antiphospholipid syndrome.

Lavoipierre V, Talbot M, Soubrier C, De Sainte Marie B, Seux V, Solas C, Morange P, Bernit E, Ebbo M, Faucher B, Harlé JR, Schleinitz N.

Rev Med Interne. 2020 Jul;41(7):489-492.

 

 

• Section sur le COVID 19

​

• ​COVID-19 outcomes in patients with inflammatory rheumatic and musculoskeletal diseases treated with rituximab: a cohort study.

Avouac J, Drumez E, Hachulla E, Seror R, Georgin-Lavialle S, El Mahou S, Pertuiset E, Pham T, Marotte H, Servettaz A, Domont F, Chazerain P, Devaux M, Claudepierre P, Langlois V, Mekinian A, Maria ATJ, Banneville B, Fautrel B, Pouchot J, Thomas T, Flipo RM, Richez C; FAI2R/SFR/SNFMI/SOFREMIP/CRI/IMIDIATE consortium and contributors

Lancet Rheumatol. 2021 Jun;3(6):e419-e426.

 

• Overweight is an independent risk factor for severe forms of COVID-19. L Pietri, A Bégu, M Lojou, M Koubi, R Cauchoix, R Grangeot, N Dubois, R Giorgi, G Kaplanski, R Valéro, S Béliard.

Metabolism. 2021 Jan 6;117:154703 doi: 10.1016/j.metabol.2021.154703

• Factors associated with dexamethasone efficacy in COVID-19. A retrospective investigative cohort study.

Arcani R, Cauchois R, Suchon P, Jean R, Jarrot PA, Gomes De Pinho Q, Dalmas JB, Jean E, Andre B, Veit V, Koubi M, Kaplanski G.

J Med Virol. 2022 Jul;94(7):3169-3175. doi: 10.1002/jmv.27712. Epub 2022 Mar 24

 

• Factors associated with COVID-19-related death in people with rheumatic diseases: results from the COVID-19 Global Rheumatology Alliance physician-reported registry.

Strangfeld A, Schäfer M, Gianfrancesco MA, Lawson-Tovey S, Liew JW, Ljung L, Mateus EF, Richez C, Santos MJ, Schmajuk G, Scirè CA, Sirotich E, Sparks JA, Sufka P, Thomas T, Trupin L, Wallace ZS, Al-Adely S, Bachiller-Corral J, Bhana S, Cacoub P, Carmona L, Costello R, Costello W, Gossec L, Grainger R, Hachulla E, Hasseli R, Hausmann JS, Hyrich KL, Izadi Z, Jacobsohn L, Katz P, Kearsley-Fleet L, Robinson PC, Yazdany J, Machado PM; COVID-19 Global Rheumatology Alliance.

Ann Rheum Dis. 2021 Jul;80(7):930-942.

 

• Severity of COVID-19 and survival in patients with rheumatic and inflammatory diseases: data from the French RMD COVID-19 cohort of 694 patients.

FAI2R /SFR/SNFMI/SOFREMIP/CRI/IMIDIATE consortium and contributors.

Ann Rheum Dis. 2020 Dec 2;80(4):527-38. doi: 10.1136/annrheumdis-2020-218310. 

 

• Discrimination of COVID‐19 from inflammation‐induced cytokine storm syndromes by disease‐related blood biomarkers

Christoph Kessel, Richard Vollenberg, Katja Masjosthusmann, Claas Hinze, Helmut Wittkowski, France Debaugnies, Carole Nagant, Francis Corazza, Frédéric Vély, Gilles Kaplanski, Charlotte Girard‐Guyonvarc’h, Cem Gabay, Hartmut Schmidt, Dirk Foell, Phil‐Robin Tepasse.

Arthritis Rheumatol. 2021 Apr 20 : 10.1002/art.41763. doi: 10.1002/art.41763

 

• Evolution Toward Severe Covid-19 From Biological Monitoring to Therapeutic Considerations

Julien Carvelli, Audrey Le Saux, Jeremy Bourenne, Marc Gainnier, Gilles Kaplanski

Front Immunol. 2020; 11: 562038. Published online 2020 Dec 15. doi: 10.3389/fimmu.2020.562038

 

• Early IL-1 receptor blockade in severe inflammatory respiratory failure complicating COVID-19

Raphaël Cauchois, Marie Koubi, David Delarbre, Cécile Manet, Julien Carvelli, Valery Benjamin Blasco, Rodolphe Jean, Louis Fouche, Charleric Bornet, Vanessa Pauly, Karin Mazodier, Vincent Pestre, Pierre-André Jarrot, Charles A. Dinarello, Gilles Kaplanski

Proc Natl Acad Sci U S A. 2020 Aug 11; 117(32): 18951–18953. Published online 2020 Jul 22. doi: 10.1073/pnas.2009017117

 

• Circulating Endothelial Cells as a Marker of Endothelial Injury in Severe COVID -19

Christophe Guervilly, Stephane Burtey, Florence Sabatier, Raphaël Cauchois, Guillaume Lano, Evelyne Abdili, Florence Daviet, Laurent Arnaud, Philippe Brunet, Sami Hraiech, Noémie Jourde-Chiche, Marie Koubi, Romaric Lacroix, Léa Pietri, Yaël Berda, Thomas Robert, Clara Degioanni, Mélanie Velier, Laurent Papazian, Gilles Kaplanski, Françoise Dignat-George

J Infect Dis. 2020 Aug 19 : jiaa528. Published online 2020 Aug 19. doi: 10.1093/infdis/jiaa528

 

• Dissemination of extreme levels of extracellular vesicles: tissue factor activity in patients with severe COVID-19

Christophe Guervilly, Amandine Bonifay, Stephane Burtey, Florence Sabatier, Raphaël Cauchois, Evelyne Abdili, Laurent Arnaud, Guillaume Lano, Léa Pietri, Thomas Robert, Mélanie Velier, Laurent Papazian, Jacques Albanese, Gilles Kaplanski, Françoise Dignat-George, Romaric Lacroix

Blood Adv. 2021 Feb 9; 5(3): 628–634. 

 

• COVID-19 as a potential trigger of complement-mediated atypical HUS

Carine El Sissy, Antonin Saldman, Gilbert Zanetta, Paula Vieira Martins, Coralie Poulain, Raphaël Cauchois, Gilles Kaplanski, Jean-Pierre Venetz, Mickaël Bobot, Hélène Dobosziewicz, Laurent Daniel, Marie Koubi, Salima Sadallah, Samuel Rotman, Christiane Mousson, Manuel Pascual, Véronique Frémeaux-Bacchi, Fadi Fakhouri

Blood. 2021 Nov 4; 138(18): 1777–1782. doi: 10.1182/blood.2021012752

 

• Clinical characteristics and outcomes of patients with haematologic malignancies and COVID-19 suggest that prolonged SARS-CoV-2 carriage is an important issue

Robin Arcani, Julien Colle, Raphaël Cauchois, Marie Koubi, Pierre-André Jarrot, Rodolphe Jean, Arthur Boyer, Julie Lachamp, Antoine Tichadou, Anne-Laure Couderc, Laure Farnault, Regis Costello, Geoffroy Venton, Gilles Kaplanski

Ann Hematol. 2021; 100(11): 2799–2803. 

 

• Effect of anakinra on mortality in patients with COVID-19: a systematic review and patient-level meta-analysis

Evdoxia Kyriazopoulou, Thomas Huet, Giulio Cavalli, Andrea Gori, Miltiades Kyprianou, Peter Pickkers, Jesper Eugen-Olsen, Mario Clerici, Francisco Veas, Gilles Chatellier, Gilles Kaplanski, Mihai G Netea, Emanuele Pontali, Marco Gattorno, Raphael Cauchois, Emma Kooistra, Matthijs Kox, Alessandra Bandera, Hélène Beaussier, Davide Mangioni, Lorenzo Dagna, Jos W M van der Meer, Evangelos J Giamarellos-Bourboulis, Gilles Hayem, International Collaborative Group for Anakinra in COVID-19

Lancet Rheumatol. 2021 Oct; 3(10): e690–e697. 

 

• Excess body weight is an independent risk factor for severe forms of COVID-19

Léa Pietri, Roch Giorgi, Audrey Bégu, Manon Lojou, Marie Koubi, Raphael Cauchois, Rachel Grangeot, Noémie Dubois, Gilles Kaplanski, René Valéro, Sophie Béliard

Metabolism. 2021 Apr; 117: 154703. 

 

• Combined Anakinra and Ruxolitinib treatment to rescue extremely ill COVID-19 patients: A pilot study.

Gilles Kaplanski, Denis Bontemps, Pierre Esnault, Valery Blasco, Julien Carvelli, David Delarbre, Raphael Cauchois, Jean-Marie Forel, Laurent Papazian

Autoimmun Rev. 2021 Feb; 20(2): 102726. 

 

• Factors associated with dexamethasone efficacy in COVID19. A retrospective investigative cohort study. Robin Arcani, Raphael Cauchois, Pierre Suchon, Rodolphe jean, Pierre-André Jarrot, Quentin Gomes de Pinho, Jean-Baptiste Dalmas, Estelle Jean, Baptiste André, Véronique Veit, Marie Koubi, Gilles Kaplanski. 

J Med Virol. Sous presse

 

• Association of COVID-19 inflammation with activation of the C5a-C5aR1 axis.

Carvelli J, Demaria O, Vély F, Batista L, Chouaki Benmansour N, Fares J, Carpentier S, Thibult ML, Morel A, Remark R, André P, Represa A, Piperoglou C; Explore COVID-19 IPH group; Explore COVID-19 Marseille Immunopole group, Cordier PY, Le Dault E, Guervilly C, Simeone P, Gainnier M, Morel Y, Ebbo M, Schleinitz N, Vivier E. 

Nature. 2020 Dec;588(7836):146-150.

 

 

• Dans les myosites et myofasciites                                            

 

•  Considering the level of myositis-specific autoantibodies could improve the precision of multiplex assay : lesson from patients with multiple positive results

Briantais A, De Sainte Marie B, Campana-Salort E, Kaplanski G, Durand JM, Bertin D, Bardin N, Ebbo M, Schleinitz N. 

Semin Arthritis Rheum. 2022Feb;52:151871. 

 

• Inflammatory myopathies associated with myelodysplastic syndromes:

A French multicenter case control study and literature review

Briantais A, Séguier J, De Sainte Marie B, Mekinian A, Belizna C, Gondran G, Maurier F, Trouiller S, Willems L, Beyne-Rauzy O, Harlé JR, Vey N, Ebbo M, Schleinitz N; MINHEMON (French Network of dysimmune disorders associated with hemopathies). Semin Arthritis Rheum. 2021 Aug;51(4):845-852.

 

• Systematic retrospective study of 64 patients with anti-Mi2 dermatomyositis: A classic skin rash with a necrotizing myositis and high risk of malignancy

Monseau G, Landon-Cardinal O, Stenzel W, Schoindre Y, Mariampillai K, Barete S, Martel C, Masseau A, Meyer A, Terrier B, Guégan S, Verneuil L, Audia S, Livideanu CB, Hachulla E, Kahn JE, Lefevre G, Maurier F, Moulis G, Papo T, Dossier A, Descamps V, Salort-Campana E, Richard MA, Bergot E, Mortier L, Costedoat-Chalumeau N, Genot S, Perez F, Piette AM, Samson M, Schleinitz N, Zénone T, Lacoste M, de Boysson H, Madaule S, Rigolet A, Champtiaux N, Hervier B, Bouvier AM, Jooste V, Léonard-Louis S, Maisonobe T, Aouba A, Benveniste O, Bienvenu B, Allenbach Y; French Myositis Network.  

J Am Acad Dermatol. 2020 Dec;83(6):1759-1763.

 

• Nailfold videocapillaroscopy alterations in dermatomyositis, antisynthetase syndrome, overlap myositis, and immune-mediated necrotizing myopathy

Soubrier C, Seguier J, Di Costanzo MP, Ebbo M, Bernit E, Jean E, Veit V, Swiader L, Salort-Campana E, Attarian S, De Paula AM, Kaplanski G, Durand JM, Harlé JR, Schleinitz N.  

Clin Rheumatol. 2019 Dec;38(12):3451-3458.

 

• Acute myositis: an unusual and severe side effect of docetaxel: a case report and literature review 

Rochigneux P, Schleinitz N, Ebbo M, Aymonier M, Pourroy B, Boissier R, Salas S, Deville JL.  

Anticancer Drugs. 2018 Jun;29(5):477-481.

 

• Trunk involvement and peau d'orange aspect are poor prognostic factors in eosinophilic fasciitis (Shulman's disease): a multicenter retrospective study of 119 patients

Zuelgaray E, Chevret S, Jachiet M, Cacoub P, Kahn JE, Groh M, Granel B, Scafi M, Geffray L, Chasset F, Gatfosse M, Mekinian A, Lioger B, Mahr A, Gaches F, Michaud M, Ludot I, Cordoliani F, de Masson A, Cassius C, Retornaz F, Audemard-Verger A, Lartigau-Roussin C, Roriz M, Chaigne B, Pallure V, Marie I, Castel B, Loustau V, Chiche L, Gavand PE, Cathebras P, Barete S, Frances C, Brenaut E, Allenbach Y, Benveniste O, Noel N, Urbanski G, Hinschberger O, Bessis D, Bagot M, Bouaziz JD, Sène D; EMSED (Etude des Maladies Systémiques en Dermatologie, Société Française de Dermatologie/Study Group of Systemic Diseases in Dermatology, French Society of Dermatology); SNFMI (Société Nationale Française de Médecine Interne/French National Society of Internal Medicine); CEREO (Centre National de Référence des Syndromes Hyperéosinophiliques). 

J Am Acad Dermatol. 2020 Nov 11:S0190-9622(20)33014-0. doi: 10.1016/j.jaad.2020.11.009. 

 

• Clinical value of a [18F]-FDG PET-CT muscle-to-muscle SUV ratio for the diagnosis of active dermatomyositis

Martis N, Viau P, Zenone T, Andry F, Grados A, Ebbo M, Castela E, Brihaye B, Denis E, Liguori S, Audemard A, Schoindre Y, Morin AS, Terrier B, Marcq L, Mounier N, Lidove O, Chaborel JP, Quinsat D. 

Eur Radiol. 2019 Dec;29(12):6708-6716.

 

 

• Dans les maladies auto-inflammatoires

 

•  Interleukin‐18: Biological properties and role in disease pathogenesis. Gilles Kaplanski. 

Immunol Rev. 2018 Jan; 281(1): 138–153. 

 

• Indeed, IL-18 is more than an inducer of IFNγ.Charles Anthony Dinarello, Gilles Kaplanski. 

J Leukoc Biol. 2018 Aug; 104(2): 237–238.

 

• Functional and genetic testing in adults with HLH reveals an inflammatory profile rather than a cytotoxicity defect

Julien Carvelli, Christelle Piperoglou, Catherine Farnarier, Frédéric Vely, Karin Mazodier, Sandra Audonnet, Patrick Nitschke, Christine Bole-Feysot, Mohamed Boucekine, Audrey Cambon, Mohamed Hamidou, Jean-Robert Harle, Geneviève de Saint Basile, Gilles Kaplanski. 

Blood. 2020 Jul 30; 136(5): 542–552. 

 

• High Mortality of HLH in ICU Regardless Etiology or Treatment

Amandine Bichon, Jérémy Bourenne, Jérôme Allardet-Servent, Laurent Papazian, Sami Hraiech, Christophe Guervilly, Vanessa Pauly, Gilles Kaplanski, Djamel Mokart, Marc Gainnier, Julien Carvelli

Front Med (Lausanne) 2021; 8: 735796

 

• Acute severe hepatitis in adult-onset Still's disease: case report and comprehensive review of a life-threatening manifestation. 

Muller R, Briantais A, Faucher B, Borentain P, Nafati C, Blasco V, Gregoire E, Bernit E, Seguier J, Meunier B, Harlé JR, Ebbo M, Schleinitz N. 

Clin Rheumatol. 2021 Jun;40(6):2467-2476.

 

• Des lésions oculaires et cutanées. Gomes de Pinho Q, De Sainte Marie B, Seguier J, Ebbo M, Schleinitz N.

Rev Med Interne, 2022. https://doi.org/10.1016/j.revmed.2022.04.029

 

 

• Dans la maladie associée aux IGG4

 

• Blood biomarkers recommended for diagnosing and monitoring IgG4-related disease. Considerations from the ERN ReCONNET and collaborating partners

Iaccarino L, Talarico R, Bozzalla-Cassione E, Burmester GR, Culver EL, Doria A, Ebbo M, van Hagen PM, Hachulla E, van Laar JAM, Lanzillotta M, Martinez-Valle F, Montecucco C, Monti S, Nalli C, Schleinitz N, Tincani A, Della Torre E, Alexander T. 

Clin Exp Rheumatol. 2022 

 

•  A descriptive study of IgG4-related disease in children and young adults

de Sainte Marie B, Ebbo M, Grados A, Rebours V, Reumaux H, Briantais A, Urbina D, Cury J, Morel N, Lhote F, Rohmer B, Lazaro E, Agbo-Kpati KP, Deroux A, Domont F, Delacroix I, Lavigne C, Perlat A, Kahn JE, Godeau B, Hamidou M, Launay D, Bader-Meunier B, Schleinitz N. 

Autoimmun Rev. 2022 Jan 4;21(4):103035.

 

• Thoracic involvement and imaging patterns in IgG4-related disease

Muller R, Habert P, Ebbo M, Graveleau J, Groh M, Launay D, Audia S, Pugnet G, Cohen F, Perlat A, Benyamine A, Bienvenu B, Gaigne L, Chanez P, Gaubert JY, Schleinitz N. 

Eur Respir Rev. 2021 Oct 5;30(162):210078. 

 

• IgG4-related disease and hypereosinophilic syndrome: Overlapping phenotypes

Moussiegt A, Müller R, Ebbo M, Grados A, Graveleau J, Ackermann F, Bachmeyer C, Bernit E, Blanche P, Canoui E, Chaix F, Costedoat-Chalumeau N, Groote P, Etienne N, Fior R, Flamarion E, Kennel T, Launay D, Lerolle N, Limal N, Loustau V, Menage E, Moulis G, Papo T, Pouchot J, Quemeneur T, Roumier M, Tchérakian C, Lefèvre G, Rebours V, Kahn JE, Schleinitz N, Groh M; CEREO; French IgG4-RD Study Group. 

Autoimmun Rev. 2021 Sep;20(9):102889. 

 

• Emerging therapy options for IgG4-related disease

Lanzillotta M, Fernàndez-Codina A, Culver E, Ebbo M, Martinez-Valle F, Schleinitz N, Della-Torre E.  Expert Rev Clin Immunol. 2021 May;17(5):471-483. 

 

• Maladie associée aux IgG4 : des critères « diagnostiques » aux critères de classification ACR/EULAR 2019 

Schleinitz N, Briantais A, Ebbo M.

Rev Med Interne. 2020 Dec;41(12):814-821. 

 

• UEG guideline working group. European Guideline on IgG4-related digestive disease - UEG and SGF evidence- based recommendations

Löhr JM, Beuers U, Vujasinovic M, Alvaro D, Frøkjær JB, Buttgereit F, Capurso G, Culver EL, de-Madaria E, Della-Torre E, Detlefsen S, Dominguez-Muñoz E, Czubkowski P, Ewald N, Frulloni L, Gubergrits N, Duman DG, Hackert T, Iglesias-Garcia J, Kartalis N, Laghi A, Lammert F, Lindgren F, Okhlobystin A, Oracz G, Parniczky A, Mucelli RMP, Rebours V, Rosendahl J, Schleinitz N, Schneider A, vanBommel EF, Verbeke CS, Vullierme MP, Witt H.

United European Gastroenterol J. 2020 Jul;8(6):637-666.

 

• IgG4 hypophysitis: Diagnosis and management

Lojou M, Bonneville JF, Ebbo M, Schleinitz N, Castinetti F. 

Presse Med. 2020 Apr;49(1):104016. doi:

 

• Pathophysiology of IgG4-related disease: A T follicular helper cells disease? 

De Sainte Marie B, Urban ML, Vély F, Seguier J, Grados A, Daniel L, Ebbo M, Schleinitz N. 

Presse Med. 2020 Apr;49(1):104013. 

 

• Dupilumab as a novel steroid-sparing treatment for IgG₄-related disease

Ebbo M, De Sainte-Marie B, Muller R, Piperoglou C, Grados A, Vély F, Schleinitz N.  

Ann Rheum Dis.2022 Feb;81(2):e26. 

 

• The 2019 American College of Rheumatology/European League Against Rheumatism classification

criteria for IgG4-related disease. 

Wallace ZS, Naden RP, Chari S, Choi HK, Della-Torre E, Dicaire JF, Hart PA, Inoue D, Kawano M, Khosroshahi A, Lanzillotta M, Okazaki K, Perugino CA, Sharma A, Saeki T, Schleinitz N, Takahashi N, Umehara H, Zen Y, Stone JH; Members of the ACR/EULAR IgG4-RD Classification Criteria Working Group. Ann Rheum Dis. 2020 Jan;79(1):77-87. 

 

• The 2019 American College of Rheumatology/European League Against Rheumatism Classification Criteria for IgG4-Related Disease.

Wallace ZS, Naden RP, Chari S, Choi H, Della-Torre E, Dicaire JF, Hart PA, Inoue D, Kawano M, Khosroshahi A, Kubota K, Lanzillotta M, Okazaki K, Perugino CA, Sharma A, Saeki T, Sekiguchi H, Schleinitz N, Stone JR, Takahashi N, Umehara H, Webster G, Zen Y, Stone JH; American College of Rheumatology/European League Against Rheumatism IgG4-Related Disease Classification Criteria Working Group. 

Arthritis Rheumatol. 2020 Jan;72(1):7-19.

 

• Clinical presentation, treatment and outcome of IgG4-related pachymeningitis: From a national case registry and literature review. 

Melenotte C, Seguier J, Ebbo M, Kaphan E, Bernit E, Saillier L, Audoin B,

Feyeux D, Daniel L, Roche PH, Graillon T, Dufour H, Boutière C, Girard N, Closs- Prophette F, Guillaud C, Tieulié N, Regent A, Harlé JR, Hamidou M, Mekinian A, Grados A, Schleinitz N. 

Semin Arthritis Rheum. 2019 Dec;49(3):430-437. 

 

• Clinical phenotypes of IgG4-related disease: an analysis of two international cross-sectional cohorts Wallace ZS, Zhang Y, Perugino CA, Naden R, Choi HK, Stone JH; ACR/EULAR IgG4-RD Classification Criteria Committee. 

Ann Rheum Dis. 2019 Mar;78(3):406-412. 

 

• International Multispecialty Validation Study of the IgG4-Related Disease Responder Index

Wallace ZS, Khosroshahi A, Carruthers MD, Perugino CA, Choi H, Campochiaro C, Culver EL, Cortazar F, Della-Torre E, Ebbo M, Fernandes A, Frulloni L, Hart PA, Karadag O, Kawa S, Kawano M, Kim MH, Lanzillotta M, Matsui S, Okazaki K, Ryu JH, Saeki T, Schleinitz N, Tanasa P, Umehara H, Webster G, Zhang W, Stone JH. 

Arthritis Care Res (Hoboken). 2018 Nov;70(11):1671-16782.

 

• Clinical features and outcomes of COVID-19 in patients with IgG4-related disease: a European multi-center study.

Ramirez GA, Lanzillotta M, Ebbo M, Fernandez-Codina A, Mancuso G, Orozco-Galvez O, Dagna L, Schleinitz N, Martínez-Valle F, Culver EL, Della-Torre E. Rheumatology (Oxford). 2021 Dec 17:keab930.